Jul 2026· World Journal of Gastrointestinal Oncology· 0 citations· 33 references
TL;DR
YWXY alleviates gastric mucosal injury in combined SPEM and SSDS by regulating IL-1β and TNF-α, restoring the miR-7a-5p/Cdr1as axis, and suppressing WFDC2 expression, which indicates coordinated regulation of inflammatory cytokines, ncRNA networks, and metaplastic markers.
Abstract
Background
Gastric cancer develops through a sequence of atrophy, metaplasia, and dysplasia. Spasmolytic polypeptide-expressing metaplasia (SPEM) is a pivotal precancerous lesion associated with inflammation and noncoding RNA dysregulation. In traditional Chinese medicine (TCM), these pathological changes overlap with spleen-stomach deficiency syndrome (SSDS). Yiwei Xiaoyu granules (YWXY), a classical TCM formula, have demonstrated clinical benefit in chronic atrophic gastritis, yet their mechanistic actions in SPEM combined with SSDS remain unclear.
Aim
To investigate the protective effects and mechanisms of YWXY in a tamoxifen-induced SPEM and SSDS composite model.
Methods
A mouse model of tamoxifen-induced SPEM, with or without SSDS, was established. The effects of YWXY on gastric mucosa were evaluated by histological scoring, quantitative polymerase chain reaction (qPCR), and fluorescence in situ hybridization (FISH). Key molecular endpoints included inflammatory cytokines [interleukin (IL)-1β and tumor necrosis factor (TNF)-α], the miR-7a-5p/Cdr1as axis, and the metaplastic marker WFDC2. Statistical analysis was performed using two-way analysis of variance followed by Tukey’s multiple comparisons.
Results
YWXY exhibited time-dependent modulation of IL-1β, normalizing its expression at day 15 and suppressing persistent elevation at day 30. TNF-α overexpression in SPEM was significantly reduced by YWXY at both time points. Cdr1as downregulation in pathological groups was partially reversed by YWXY, while miR-7a-5p suppression in SSDS and SPEM + SSDS was restored toward baseline. WFDC2 induction in both SPEM and SSDS was significantly attenuated by YWXY, confirmed by qPCR and FISH. These findings indicate coordinated regulation of inflammatory cytokines, ncRNA networks, and metaplastic markers.
Conclusion
YWXY alleviates gastric mucosal injury in combined SPEM and SSDS by regulating IL-1β and TNF-α, restoring the miR-7a-5p/Cdr1as axis, and suppressing WFDC2 expression.
Findings suggest that PPP mitigates CAG and attenuates IM at least in part by suppressing the Pellino1/IRAK1/NF‐κB signaling pathway, indicating that it may serve as a promising therapeutic strategy for reducing inflammation‐associated gastric carcinogenesis.
Cheng Zhang, Fei Lu, Ting Ye et al.· Cell Biology International· 0 citations
HJSS alleviates MNNG-induced CAG by attenuating inflammatory injury and promoting the recovery of gastric mucosal barrier-associated molecular features, supporting an inflammation–barrier mechanism underlying the action of HJSS in CAG.
Shuo Zhang, Shuya Zhang, Mengyi Wang et al.· Frontiers in Immunology· 0 citations
Gastric intestinal metaplasia (GIM) is a typical precancerous lesion of gastric cancer (PLGC). Previous studies have demonstrated that Xinkai Kujiang formula can effectively alleviate GIM, but its underlying mechanism remains largely unclear.
The GIM rat model was established using 2% sodium salicylate and 2...
Jiao Xiang, Yu-Qin Cheng, Zhaolin Wang et al.· Frontiers in Pharmacology· 0 citations
Evaluating the preventive and therapeutic effects of RQMJ on CAG and its intervention in the inflammation–cancer transition process highlights the potential pharmacological value and therapeutic prospects of RQMJ in inflammation-driven gastric diseases.
Fengyu Huang, Peiping Chen, Daiyue Ding et al.· Chinese Medicine· 0 citations
This review summarizes current knowledge on cellular plasticity, lineage dynamics, and molecular mechanisms underlying SPEM formation and progression in CAG and focuses on recent advances in oxyntic atrophy, immune cell and inflammation, as well as oxidative stress in gastric epithelial remodeling.
Xin Quan, Ling-Long Ji, Tian He et al.· Journal of Digestive Disease...· 0 citations
It is demonstrated that HEP exerts gastroprotective effects against CAG through coordinated anti-inflammatory, antioxidant, and structure-dependent NF-κB inhibitory actions, supporting its potential as a promising natural agent for CAG intervention.
Ping Li, Jianran Hu, Yan-juan Yang et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.